Strain Information | |
---|---|
Image | |
BRC No. | RBRC06164 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6;129-Edn2<tm1Ywa> |
Former Common name | ET2/129, B6-Edn2 KO |
H-2 Haplotype | |
ES Cell line | SM1[129S6/SvEvTac] |
Background strain | |
Appearance | |
Strain development | Developed by Masashi Yanagisawa, The University of Texas Southwestern Medical Center. SM1 ES cells were used to generate the mutant mice. 129 and C57BL/6 mixed background. |
Strain description | ET-2 (Edn2 / endothelin 2) gene knockout mice. Part of exon 1 and all of exon 2 were replaced with a neomycin resistant gene. Homozygous mutant mice die after birth (3-4 weeks of age). |
Colony maintenance | Heterozygote x Wild-type [or Crossing to C57BL/6J(Crlj)] |
References | Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. Chang I, Bramall A N, Baynash A G, Rattner A, Rakheja D, Post M, Joza S, McKerlie C, Stewart D J, McInnes R R, Yanagisawa M J. Clin Invest., 123, 2643-2653 (2013). 23676500 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Edn2 MGI:95284 | endothelin 2 | 4 | Edn2<tm1Ywa> MGI:5519239 | targeted mutation 1, Masashi Yanagisawa | |||
GH | Growth hormone polyA (Bovine) | 4 | GH | ||||
neo | neomycin resistance gene (E. coli) | 4 | mouse RNA polymerase II promoter |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 24 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | mouse RNA polymerase II promoter, E. coli Neomycin resistance gene, bovine growth hormone polyadenylation site, mouse Edn2 genomic DNA |
Research application | Developmental Biology Research Hematological Research |
Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. J. Clin Invest., 123, 2643-2653 (2013). Depositor limits the use of the BIOLOGICAL RESOURCE to not-for-profit institutions. Depositor limits the use of the BIOLOGICAL RESOURCE to academic purposes. For-profit institutions and recipients who intend to use BIOLOGICAL RESOURCE for commercial research purposes shall acquire prior written consent from the Depositor. Recipient shall acquire prior written consent from the Depositor prior to filing an application for patent, or intellectual property or other rights based on the results of research using the BIOLOGICAL RESOURCE. |
Depositor | Masashi Yanagisawa (University of Texas Southwestern Medical Center at Dallas) |
Strain Status | ![]() |
Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |